Actavis to Build Three Plants in India; Opens Laboratories

Generics pharmaceutical manufacturer Actavis (Hafnarfjordur, Iceland) says it is building three pharmaceutical plants in India. Actavis recently broke ground on a pilot plant and an active pharmaceutical ingredient (API) plant at the company’s existing API facility at Alathur, in southern India. The company says it has also begun construction of a solid oral dosage (SOD) plant at its existing SOD site at Alathur. Investment amounts were not disclosed. Construction of the three plants is expected to be completed in 2009. The new API plant and pilot facility...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers